Compugen Reports First Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Compugen (CGEN) PT Raised to $5 at Truist Securities
May 20, 2024 1:21 PM EDTTruist Securities analyst Asthika Goonewardene raised the price target on Compugen (NASDAQ: CGEN) to $5.00 (from $4.00) while maintaining a Buy rating.
The analyst comments "We are dismayed to learn that CGEN's efforts to develop COM701+COM902 in a particularly tough indication for immunotherapy... More



